DTC Act of 2025
Latest action · Jan 23, 2025 Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 23, 2025
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025
This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.
Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.
The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.
Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Cosponsors 9
Members who signed on, in the order they did. Signatures ran from Jan 23, 2025 to Jan 28, 2025; 8 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| I-ME | Angus S. King Jr. | Original | Jan 23, 2025 |
| R-IA | Chuck Grassley | Original | Jan 23, 2025 |
| R-IA | Joni Ernst | Original | Jan 23, 2025 |
| D-VT | Peter Welch | Original | Jan 23, 2025 |
| D-CT | Richard Blumenthal | Original | Jan 23, 2025 |
| D-WI | Tammy Baldwin | Original | Jan 23, 2025 |
| D-MN | Tina Smith | Original | Jan 23, 2025 |
| R-AL | Tommy Tuberville | Original | Jan 23, 2025 |
| R-MS | Cindy Hyde-Smith | Jan 28, 2025 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Jan 23, 2025 |
Actions 2
Everything that happened, newest first.
- Jan 23, 2025Introduced in Senate
- Jan 23, 2025Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S8251 | Richard J. Durbin D-IL | Nov 20, 2025 |
| Senate | Debate and remarks S4585–S4587 | Chuck Grassley R-IA, Mike Crapo R-ID, Richard J. Durbin D-IL | Jul 23, 2025 |
| Senate | Debate and remarks S337Text printed S337 | Richard J. Durbin D-IL (text) | Jan 23, 2025 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 3789 | DTC Act of 2025 | Identical bill | Jun 5, 2025 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.
- Short Title(s) as Introduced
- DTC Act of 2025
- Drug-price Transparency for Consumers Act of 2025
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jan 23, 2025Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
